{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:46:28Z","timestamp":1648719988258},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1001\/jamadermatol.2019.1404","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T15:33:55Z","timestamp":1561563235000},"page":"1084","source":"Crossref","is-referenced-by-count":2,"title":["Severe Lipodystrophy Following Prolonged Subcutaneous Administration of Antisense Oligonucleotides"],"prefix":"10.1001","volume":"155","author":[{"given":"Anh Ly","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Anne","family":"Morren","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"dlo190010r1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.15252\/emmm.201607199","article-title":"Delivery is key: lessons learnt from developing splice-switching antisense therapies.","volume":"9","author":"Godfrey","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"2","key":"dlo190010r2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/bcp.12961","article-title":"Injection site reactions after subcutaneous oligonucleotide therapy.","volume":"82","author":"van Meer","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"dlo190010r3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00431-018-3272-1","article-title":"Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study.","volume":"178","author":"Hilhorst","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"10","key":"dlo190010r4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1474-4422(09)70229-7","article-title":"Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.","volume":"8","author":"Aartsma-Rus","year":"2009","journal-title":"Lancet Neurol"},{"issue":"4","key":"dlo190010r5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.det.2008.05.013","article-title":"Factitial panniculitis.","volume":"26","author":"Sanmart\u00edn","year":"2008","journal-title":"Dermatol Clin"},{"key":"dlo190010r6","unstructured":"The human protein atlas. Tissue expression of DMD. https:\/\/www.proteinatlas.org\/ENSG00000198947-DMD\/tissue#top. Accessed November 28, 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/article-pdf\/155\/9\/1084\/17896618\/jamadermatology_nguyen_2019_lo_190010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T15:01:07Z","timestamp":1568214067000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2736965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.1404","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}